APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOKBy ApyxMedical|2025-12-12T19:47:02+00:00May 8, 2019|
APYX MEDICAL CORPORATION PROVIDES UPDATE ON THE PREMARKET NOTIFICATION 510(K) SUBMISSION TO THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR USE IN DERMAL RESURFACING PROCEDURES; PROVIDES PRELIMINARY FIRST QUARTER 2019 REVENUE RESULTS AND REAFFIRMS 2019 REVENUE OUTLOOKBy ApyxMedical|2025-12-12T19:47:27+00:00April 1, 2019|
APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON MAY 8, 2019By ApyxMedical|2025-12-12T19:47:50+00:00April 1, 2019|
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS AND INTRODUCES FISCAL YEAR 2019 OUTLOOKBy ApyxMedical|2025-12-12T19:48:15+00:00March 13, 2019|
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS ON MARCH 13, 2019By ApyxMedical|2025-12-12T19:48:36+00:00February 7, 2019|
APYX MEDICAL CORPORATION ANNOUNCES THE PROMOTION OF TODD HORNSBY TO EXECUTIVE VICE PRESIDENTBy ApyxMedical|2025-12-12T19:48:59+00:00January 14, 2019|
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FULL YEAR AND FOURTH QUARTER 2018 REVENUE RESULTSBy ApyxMedical|2025-12-12T19:49:19+00:00January 7, 2019|
